TruVerus System & Assay Menu

About Truvian Sciences

Truvian Sciences is commercializing the TruVerus™ system, which it claims is the world's first FDA-cleared multimodal automated benchtop analyzer, combining clinical chemistry, immunoassay, and hematology testing in a single, compact instrument. The company employs a staged FDA clearance strategy, having already secured clearances for a panel of routine tests including metabolic panels, liver enzymes, lipids, and a CBC with differential, with more assays under review. Truvian's value proposition targets decentralized care settings by eliminating sample send-outs, reducing blood volume requirements, and providing rapid results to enable timely clinical decisions.